Reduction of 4-cyclohexyl-1-[(1R)-1,2-diphenylethyl]-piperazine-induced memory impairment of passive avoidance performance by σ1 receptor agonists in mice

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 20, Issue 7, 1998, Pages 575-580

  Matsuno, Kiyoshi ^a   Senda, Toshihiko ^a   Kobayashi, Tetsuya ^a   Murai, Masaaki ^a   Mita, Shiro ^a  

^a SANTEN PHARMACEUTICAL CO LTD   (Japan)

Author keywords

1 Receptor subtype; (+) 3 PPP; (+) SKF 10,047; 4 Cyclohexyl 1 (1R) 1,2 diphenylethyl piperazine (CDEP); DTG; Learning and memory; Mice; Passive avoidance performance

Indexed keywords

1,3 BIS(2 METHYLPHENYL)GUANIDINE; N ALLYLNORMETAZOCINE; OPIATE AGONIST; PIPERAZINE DERIVATIVE; PRECLAMOL; RECEPTOR SUBTYPE; SIGMA 1 OPIATE RECEPTOR;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; CONFERENCE PAPER; DRUG EFFECT; DRUG RECEPTOR BINDING; GUINEA PIG; INTRAPERITONEAL DRUG ADMINISTRATION; LEARNING; MALE; MEMORY; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; RECEPTOR AFFINITY; SUBCUTANEOUS DRUG ADMINISTRATION; TASK PERFORMANCE;

ANIMALS; ANTIPSYCHOTIC AGENTS; AVOIDANCE LEARNING; BINDING, COMPETITIVE; BRAIN CHEMISTRY; DOPAMINE AGONISTS; GUINEA PIGS; MALE; MEMBRANES; MEMORY DISORDERS; MICE; PHENAZOCINE; PIPERAZINES; PIPERIDINES; RADIOLIGAND ASSAY; RECEPTORS, SIGMA;

EID: 0031732231     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.1998.20.7.485721     Document Type: Conference Paper

References (24)

1. Matsuno, K., Matsunaga, K., Mita, S. Increase of extracellular acetylcholine level in rat frontal cortex induced by (+)N-allylnormetazocine as measured by brain microdialysis. Brain Res 1992, 575: 315-9.
2. Matsuno, K., Matsunaga, K., Senda, T., Mita, S. Increase in extracellular acetylcholine level by sigma ligands in rat frontal cortex. J Pharmacol Exp Ther 1993, 265: 851-9.
3. 1 receptor in (+)-N-allylnormetazocine-stimulated hippocampal cholinergic functions in rats. Brain Res 1995, 690: 200-6.
4. Kobayashi, T., Matsuno, K., Mita, S. Regional differences of the effect of σ receptor ligands on the acetylcholine release in the rat brain. J Neural Transm (Gen) 1996, 103: 661-9.
5. 2 antagonists on drug-induced impairment of Passive avoidance response in mice: comparison with acetylcholinesterase inhibitors. Psychopharmacology 1993, 112: 134-41.
6. Matsuno, K., Senda, T., Matsunaga, K., Mita, S. Ameliorating effects of σ receptor ligands on the impairment of passive avoidance tasks in mice: involvement in the central acetylcholinergic system. Eur J Pharmacol 1994, 261: 43-51.
7. Senda, T., Matsuno, K., Kobayashi, T., Mita, S. Reduction of the scopolamine-induced impairment of passive avoidance performance by σ receptor agonist in mice. Physiol Behav 1997, 61: 257-64.
8. Maurice, T., Hiramatsu, M., Itoh, J., Kameyama, T., Hasegawa, T., Nabeshima, T. Behavioral evidence for a modulating role of σ ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia. Brain Res 1994, 647: 44-56.
9. Maurice, T., Hiramatsu, M., Kameyama, T., Hasegawa, T., Nabeshima, T. Behavioral evidence for a modulating role of σ ligands in memory processes, II. Reversion of carbon monoxide-induced amnesia. Brain Res 1994, 647: 57-64.
10. Maurice, T., Roman, F.J., Su, T.-P., Privat, A. Beneficial effects of sigma agonists on the age-related learning impairment in the senescence-accelerated mouse (SAM). Brain Res 1996, 733: 219-30.
11. Jansen, K.L.R., Faull, R.L.M., Storey, P., Leslie, R.A. Loss of sigma binding sites in the CAl area of the anterior hippocampus in Alzheimer's disease correlates with CAl pyramidal cell loss. Brain Res 1993,623: 299-302.
12. Matsuno, K., Senda, T., Mita, S. Correlation between potentiation of neurogenic twitch contraction and benzomorphan σ receptor binding potency in the mouse vas deferens. Eur J Pharmacol 1993, 231: 451-7.
13. 1 receptor agonist. Eur J Pharmacol 1996, 306: 271-9.
14. 1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats. Eur J Pharmacol 1996, 315: 1-10.
15. 1 receptor agonistic properties. Behav Brain Res 1997, 83: 221-4.
16. Fujimura, H., Tsurumi, K., Nozaki, M., Hori, M., Imai, E. Analgesic activity and opiate receptor binding of 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine. Jpn J Pharmacol 1978, 28: 505-6.
17. Nozaki, M., Niwa, M., Imai, E., Hori, M., Fujimura, H. (1,2-Diphenylethyl)piperazine as potent opiate-like analgesics; the unusual relationships between stereoselectivity and affinity to opioid receptor. Life Sci 1983, 33: 431-4.
18. Itoh, J., Ukai, M., Kameyama, T. Dynorphin A-(1-13) potently improves the impairment of spontaneous alteration performance induced by the μ-selective opioid receptor agonist DAMGO in mice. J Pharmacol Exp Ther 1994, 269: 15-21.
19. Itoh, J., Ukai, M., Kameyama, T. Dynorphin A-(1-13) markedly improves scopolamine-induced impairment of spontaneous alteration performance in mice. Eur J Pharmacol 1993, 236: 341-5.
20. Okuyama, S., Imagawa, Y., Ogawa, S. et al. NE-100, a novel sigma receptor ligand: in vivo tests. Life Sci 1994, 53: 285-90.
21. 1 receptor agonist, in the rat brain. J Pharmacol Exp Ther 1996, 279: 106-13.
22. Senda, T., Matsuno, K., Kobayashi, T., Nakazawa, M., Nakata, K., Mita, S. Ameliorative effect of SA4503, a novel cognitive enhancer, on the basal forebrain-lesion-induced impairment of the spatial learning performance in rats. Pharmacol Biochem Behav 1998, 59: 129-34.
23. 25-35-amyloid peptide-induced amnesia in mice through a common mechanism. Neuroscience 1998, 83: 413-28.
24. 1 receptor agonist properties, facilitates NMDA receptor-dependent learning in mice. Eur J Pharmacol 1997, 328: 9-18.